BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY, Poggiolini I, Santos P, Dorn A, Carloni P, Vekrellis K, Attems J, McKeith I, Outeiro TF, Jensen PH, El-Agnaf OMA. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci U S A 2022;119:e2109617119. [PMID: 35353605 DOI: 10.1073/pnas.2109617119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yi S, Wang L, Wang H, Ho MS, Zhang S. Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective. IJMS 2022;23:14753. [DOI: 10.3390/ijms232314753] [Reference Citation Analysis]
2 Hmila I, Sudhakaran IP, Ghanem SS, Vaikath NN, Poggiolini I, Abdesselem H, El-agnaf OMA. Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils. ACS Chem Neurosci 2022. [DOI: 10.1021/acschemneuro.2c00362] [Reference Citation Analysis]
3 Canever JB, Soares ES, de Avelar NC, Cimarosti HI. Targeting α-synuclein post-translational modifications in Parkinson’s disease. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.114204] [Reference Citation Analysis]
4 Li M, Fan Y, Li Q, Wang X, Zhao L, Zhu M, Schroder N. Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson’s Disease Dementia. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/7165387] [Reference Citation Analysis]
5 Borland H, Rasmussen I, Bjerregaard-Andersen K, Rasmussen M, Olsen A, Vilhardt F. α-synuclein build-up is alleviated via ESCRT-dependent endosomal degradation brought about by p38MAPK inhibition in cells expressing p25α. J Biol Chem 2022;:102531. [PMID: 36162505 DOI: 10.1016/j.jbc.2022.102531] [Reference Citation Analysis]
6 Lackie RE, de Miranda AS, Lim MP, Novikov V, Madrer N, Karunatilleke NC, Rutledge BS, Tullo S, Brickenden A, Maitland MER, Greenberg D, Gallino D, Luo W, Attaran A, Shlaifer I, Del Cid Pellitero E, Schild-Poulter C, Durcan TM, Fon EA, Duennwald M, Beraldo FH, Chakravarty MM, Bussey TJ, Saksida LM, Soreq H, Choy WY, Prado VF, Prado MAM. Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo. Acta Neuropathol 2022. [PMID: 36121476 DOI: 10.1007/s00401-022-02491-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Roberts B, Theunissen F, Mastaglia FL, Akkari PA, Flynn LL. Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics? Int J Mol Sci 2022;23:9364. [PMID: 36012622 DOI: 10.3390/ijms23169364] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Altay MF, Kumar ST, Burtscher J, Jagannath S, Strand C, Miki Y, Parkkinen L, Holton JL, Lashuel HA. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.. [DOI: 10.1101/2022.05.26.493598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Landrieu I, Dupré E, Sinnaeve D, El Hajjar L, Smet-nocca C. Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools. Front Chem 2022;10:886382. [DOI: 10.3389/fchem.2022.886382] [Reference Citation Analysis]